These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23192926)

  • 1. Imaging striatal dopaminergic function in phospholipase A2 group VI-related parkinsonism.
    Agarwal P; Hogarth P; Hayflick S; MacLeod P; Kuriakose R; McKenzie J; Heffernan N; Dinelle K; Sossi V; Stoessl AJ
    Mov Disord; 2012 Nov; 27(13):1698-9. PubMed ID: 23192926
    [No Abstract]   [Full Text] [Related]  

  • 2. PLA2G6 mutations and Parkinsonism: Long-term follow-up of clinical features and neuropathology.
    Klein C; Löchte T; Delamonte SM; Braenne I; Hicks AA; Zschiedrich-Jansen K; Simon DK; Friedman JH; Lohmann K
    Mov Disord; 2016 Dec; 31(12):1927-1929. PubMed ID: 27709683
    [No Abstract]   [Full Text] [Related]  

  • 3. FMR1 gene expansion and scans without evidence of dopaminergic deficits in parkinsonism patients.
    Hall DA; Jennings D; Seibyl J; Tassone F; Marek K
    Parkinsonism Relat Disord; 2010 Nov; 16(9):608-11. PubMed ID: 20702130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical parkinsonism with severely reduced striatal dopamine uptake associated with a 16p11.2 duplication syndrome.
    Roeben B; Blum D; Gabriel H; Synofzik M
    J Neurol; 2019 Mar; 266(3):775-776. PubMed ID: 30617906
    [No Abstract]   [Full Text] [Related]  

  • 5. Modulation of dopaminergic and glutamatergic brain function: PET studies on parkinsonian rats.
    Pellegrino D; Cicchetti F; Wang X; Zhu A; Yu M; Saint-Pierre M; Brownell AL
    J Nucl Med; 2007 Jul; 48(7):1147-53. PubMed ID: 17574972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic spectrum of patients with PLA2G6 mutation and PARK14-linked parkinsonism.
    Yoshino H; Tomiyama H; Tachibana N; Ogaki K; Li Y; Funayama M; Hashimoto T; Takashima S; Hattori N
    Neurology; 2010 Oct; 75(15):1356-61. PubMed ID: 20938027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-related changes in the striatal dopaminergic system in the living brain: a multiparametric PET study in conscious monkeys.
    Harada N; Nishiyama S; Satoh K; Fukumoto D; Kakiuchi T; Tsukada H
    Synapse; 2002 Jul; 45(1):38-45. PubMed ID: 12112412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nigrostriatal system in the presymptomatic and symptomatic stages in the MPTP monkey model: a PET, histological and biochemical study.
    Blesa J; Pifl C; Sánchez-González MA; Juri C; García-Cabezas MA; Adánez R; Iglesias E; Collantes M; Peñuelas I; Sánchez-Hernández JJ; Rodríguez-Oroz MC; Avendaño C; Hornykiewicz O; Cavada C; Obeso JA
    Neurobiol Dis; 2012 Oct; 48(1):79-91. PubMed ID: 22677034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term methamphetamine-induced decreases of [(11)C]WIN 35,428 binding in striatum are reduced by GDNF: PET studies in the vervet monkey.
    Melega WP; Lacan G; Desalles AA; Phelps ME
    Synapse; 2000 Mar; 35(4):243-9. PubMed ID: 10657033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Radionuclide techniques in the diagnosis of parkinsonian syndromes].
    Pöpperl G; Tatsch K
    MMW Fortschr Med; 2004 Mar; 146(10):24-6. PubMed ID: 15347073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychoradiological evaluation of PLA2G6 gene mutations: Adult-onset dystonia-parkinsonism case report.
    Demir Unal E; Kaplan H; Dirik EB
    Parkinsonism Relat Disord; 2022 Oct; 103():150-151. PubMed ID: 36155027
    [No Abstract]   [Full Text] [Related]  

  • 12. Progression of dopaminergic depletion in a model of MPTP-induced Parkinsonism in non-human primates. An (18)F-DOPA and (11)C-DTBZ PET study.
    Blesa J; Juri C; Collantes M; Peñuelas I; Prieto E; Iglesias E; Martí-Climent J; Arbizu J; Zubieta JL; Rodríguez-Oroz MC; García-García D; Richter JA; Cavada C; Obeso JA
    Neurobiol Dis; 2010 Jun; 38(3):456-63. PubMed ID: 20304066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homozygous p.D331Y mutation in PLA2G6 in two patients with pure autosomal-recessive early-onset parkinsonism: further evidence of a fourth phenotype of PLA2G6-associated neurodegeneration.
    Xie F; Cen Z; Ouyang Z; Wu S; Xiao J; Luo W
    Parkinsonism Relat Disord; 2015 Apr; 21(4):420-2. PubMed ID: 25660576
    [No Abstract]   [Full Text] [Related]  

  • 14. Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial parkinsonism associated with mutations in the parkin gene.
    Hilker R; Klein C; Ghaemi M; Kis B; Strotmann T; Ozelius LJ; Lenz O; Vieregge P; Herholz K; Heiss WD; Pramstaller PP
    Ann Neurol; 2001 Mar; 49(3):367-76. PubMed ID: 11261512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of nigrostriatal damage and its change over weeks in a rat model of Parkinson's disease: small animal positron emission tomography studies with [(11)C]beta-CFT.
    Liu L; Wang Y; Li B; Jia J; Sun Z; Zhang J; Tian J; Wang X
    Nucl Med Biol; 2009 Nov; 36(8):941-7. PubMed ID: 19875050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe early-onset impulsive compulsive behavior and psychosis in PLA2G6-related juvenile Parkinson's disease.
    Wirth T; Weibel S; Montaut S; Bigaut K; Rudolf G; Chelly J; Tranchant C; Anheim M
    Parkinsonism Relat Disord; 2017 Aug; 41():127-129. PubMed ID: 28549837
    [No Abstract]   [Full Text] [Related]  

  • 17. PLA2G6-related parkinsonism presenting as adolescent behavior.
    Kamel WA; Al-Hashel JY; Abdulsalam AJ; Damier P; Al-Mejalhem AY
    Acta Neurol Belg; 2019 Dec; 119(4):621-622. PubMed ID: 30120687
    [No Abstract]   [Full Text] [Related]  

  • 18. [18F]-Dopa positron emission tomography imaging in early-stage, non-parkin juvenile parkinsonism.
    Pal PK; Leung J; Hedrich K; Samii A; Lieberman A; Nausieda PA; Calne DB; Breakefield XO; Klein C; Stoessl AJ
    Mov Disord; 2002 Jul; 17(4):789-94. PubMed ID: 12210877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early-onset parkinsonism linked to combined heterozygous mutations in PANK2 and PLA2G6: A case report.
    Li J; Wu T; Li C; Wu T; Qin Y; Chen X
    Parkinsonism Relat Disord; 2021 Dec; 93():71-73. PubMed ID: 34823216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of dopamine transporter single photon emission computed tomography imaging using I-123 ioflupane on diagnoses of patients with parkinsonian syndromes.
    Bairactaris C; Demakopoulos N; Tripsianis G; Sioka C; Farmakiotis D; Vadikolias K; Heliopoulos I; Georgoulias P; Tsougos I; Papanastasiou I; Piperidou C
    J Clin Neurosci; 2009 Feb; 16(2):246-52. PubMed ID: 19097795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.